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Dear Editor,
Along with other authors and some important Working
Groups (Wenham et al. 2020), we want to emphasize the
need to consider the potential different impact of policies
and public health efforts for the novel coronavirus disease
2019 (COVID-19) on men and women separately. It is
important to keep in mind (at least) two relevant points.
First, at present, specific and reliable gender analyses
regarding the main clinical and biochemical characteristics
of the COVID-19 as well as regarding important health
outcomes are not available (Wenham et al. 2020). In a
digitized world (where we can obtain a lot of data easily
and quickly), this seems to be a great shortcoming. In this
regard, it is important to remember that for various reasons
[e.g., bodyweight, sex-dependent differences in enzymatic
activity, metabolism and immunology (Whitley and Lind-
sey 2009)], women might respond to COVID-19 infection
differently and they might have a different response to
various antiviral drugs or protocol treatments being tested.
Based on data available so far, COVID-19 seems to infect
men and women similarly, although men appear to have a
higher risk of death than women as well as a higher risk of
acute respiratory distress syndrome (ARDS) or admission
in intensive care unit (indeed, men also tend to have a
higher prevalence of smoking which is related to higher
expression of ACE2, the receptor for severe acute respi-
ratory syndrome coronavirus 2) (Wenham et al. 2020; Chen
et al. 2020; Cai 2020). However, the current data stratify-
ing by gender are not still informative, and additional
observational studies are timely required to explore these
aspects. Second, the current (restrictive) measures on
travels, the closure of schools and relevant activities or the
quarantine, which are adopted in various European coun-
tries (including Italy) in order to contain the virus infection,
could have different and important repercussions on men
and women separately, given that women have often needs
that are largely different from those of men, in terms of
health, safety or everyday activity. For instance, it is
important to remember that, when compared to men,
women have distinct demands on work and family, they
have often primary roles as caregivers within families, or
they are more frequently front-line health-care workers,
thereby making them more potentially susceptible to virus
infection (Wenham et al. 2020). For such reasons, we
strongly believe that all various measures, albeit required,
should always guarantee the gender equality. In this con-
text, in addition to WHO Executive Board and Gender and
COVID-19 Working Group (Wenham et al. 2020), we want
to highlight the obligation by various health and scientific
organizations to hear the voice of women in any decision
making for the COVID-19. Too often, indeed, women are
not adequately represented in the various organizations.
Any health and scientific organization or government that
does not act by respecting and promoting gender equity
(even in this difficult moment) is abandoning the noble
purpose to improve the human health. The recent history of
outbreak of Ebola virus (Wenham et al. 2020) should help
us not to repeat the same mistakes. The battle against
COVID-19 is not the exception.
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